Showing 5,874 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Pregnancy and vertical transmission

Dolutegravir: need to consider all pros and cons before switching in pregnancy

Editor's pick
HIV i-Base
11 July 2018
Changing treatment

Dolutegravir durable with high rates of viral suppression in people who experienced virological failure with older integrase inhibitors

News
9 July 2018
HIV treatment

Reduced-Dose Darunavir Effective in Virologically Suppressed HIV-1

Editor's pick
Infectious Disease Advisor
4 July 2018
New & experimental HIV treatments

Abivax releases positive top line data from ABX464-005 phase 2a study in HIV infection

Editor's pick
Abivax press release
4 July 2018
People & personal stories

Nelson Vergel: Built to Survive

Editor's pick
Poz
29 June 2018
HIV prevention policy

'New York Times' To Condoms: Drop Dead

Editor's pick
HIV Plus
29 June 2018
Side effects

Efavirenz does not increase the risk of suicidal thoughts or depression in Ugandan adults

News
29 June 2018
Starting treatment

Rilpivirine better tolerated, less toxic and more durable than efavirenz in first-line ART

News
28 June 2018
Epidemiology & behaviour

Dispelling the Bad Myths about PrEP in that New York Times Op-Ed

Editor's pick
Jezebel
27 June 2018
Side effects

No association found between efavirenz, suicide risk

Editor's pick
Healio
26 June 2018
New & experimental HIV treatments

European Commission Grants Marketing Authorization for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection

Editor's pick
Gilead press release
25 June 2018
Vaginal rings & topical PrEP

First Multipurpose Gel Designed to Prevent HIV, HSV, and HPV Simultaneously in Women and Men Advances in Clinical Trials

Editor's pick
Population Council
25 June 2018
Pharmaceutical industry

GSK takes billion-dollar drug fight with Gilead to top AIDS meeting

Editor's pick
Reuters
25 June 2018
Ageing & HIV

What is on the minds of PLHIV in Europe in terms of their long term health?

Editor's pick
EATG
25 June 2018
Side effects

New contraindication against using darunavir/cobicistat during pregnancy

Editor's pick
HIV i-Base
25 June 2018
Drug-resistant TB

All-access for blockbuster TB drug in South Africa

Editor's pick
Health-e
19 June 2018
Resistance

Transmitted drug resistance now less likely to harm HIV treatment options, US study finds

News
19 June 2018
New & experimental HIV treatments

GSK's two-drug HIV treatment meets main goal in late stage studies

Editor's pick
Reuters
15 June 2018
How HIV works

ART Simplification Does Not Affect Systemic Inflammation in Virologically Suppressed HIV

Editor's pick
Infectious Disease Advisor
15 June 2018
Adherence

'Emotional closeness’ key to successful HIV treatment support

Editor's pick
AVERT
15 June 2018
New & experimental HIV treatments

ViiV Healthcare reports positive results for landmark phase III studies for dolutegravir and lamivudine

Editor's pick
ViiV Healthcare press release
15 June 2018
Access to healthcare

Russia’s HIV/AIDS epidemic is getting worse, not better

Editor's pick
Science
12 June 2018
New & experimental HIV treatments

Single Shot of PRO 140 mAb Cuts HIV Load in Two Thirds on Failing ART

Editor's pick
National AIDS Treatment Advocacy Project
11 June 2018
Drug interactions & pharmacokinetics

Closer Monitoring Recommended for Older Patients Treated With Dolutegravir for HIV

Editor's pick
Infectious Disease Advisor
11 June 2018